Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

TGN38A Activators

TGN38 is a well-known transmembrane protein primarily associated with the trans-Golgi network (TGN), involved in the sorting and trafficking of proteins from the Golgi apparatus to various cellular destinations. If TGN38A were a variant or related protein, activators would likely enhance its role in intracellular trafficking. Such activators could work by promoting the interaction of TGN38A with other proteins involved in vesicle formation or by stabilizing conformations that are necessary for the efficient packaging and transport of cargo molecules. The chemical structures of TGN38A activators would vary, potentially including small molecules that bind directly to the protein or larger biomolecular constructs that influence TGN38A's function through protein-protein interactions.

Exploring TGN38A activators would require a combination of cellular, biochemical, and biophysical methods. Cellular assays would be important to determine the effects of these activators on protein trafficking within the cell. For instance, fluorescence microscopy using tagged versions of TGN38A could provide visual evidence of changes in protein localization and trafficking dynamics in response to activator compounds. Biochemical assays would be needed to quantify the direct effects of the activators on TGN38A's activity, possibly through measuring the binding of cargo molecules or the assembly of vesicular coats. Moreover, biophysical studies such as surface plasmon resonance (SPR) or isothermal titration calorimetry (ITC) would be employed to analyze the interaction between TGN38A and its activators, providing insights into binding affinities and kinetical properties. To comprehend how these activators affect TGN38A at a molecular level, structural studies using techniques such as X-ray crystallography, cryo-electron microscopy, or NMR spectroscopy would be instrumental. These methods would help to elucidate the three-dimensional structure of the TGN38A-activator complex, revealing the precise mode of action of these compounds. Overall, the discovery and characterization of TGN38A activators would expand our understanding of molecular mechanisms governing intracellular transport processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Brefeldin A disrupts Golgi structure; cells may upregulate TGN38 in an attempt to compensate and restore Golgi function.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$155.00
$525.00
(1)

Monensin alters Golgi pH and ion gradients, potentially triggering a compensatory increase in TGN38 to maintain trafficking efficiency.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$59.00
$85.00
$143.00
$247.00
38
(2)

Nocodazole disrupts microtubules, which could lead to an adaptive upregulation of TGN38 to facilitate Golgi-to-ER retrograde transport.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

Tunicamycin inhibits N-linked glycosylation, causing ER stress and possibly inducing TGN38 expression as part of the unfolded protein response.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin induces ER stress by inhibiting the SERCA pump, potentially increasing TGN38 expression as part of the stress response.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

MG-132 inhibits the proteasome, potentially leading to upregulation of TGN38 as cells attempt to manage misfolded protein accumulation.